Elizabeth Betsy Hanna

Elizabeth "Betsy" Hanna has served as a member of their board of directors since October 2021. Since March 2022, Ms. Hanna has served as Executive Vice President and Chief Commercial Officer of Agendia, Inc., a provider of molecular diagnostic test solutions. Before joining Agendia, Ms. Hanna served as President and Chief Executive Officer and a board member of Clinical Genomics, Inc., a provider of cancer diagnostic solutions, since January 2019. From October 2018 until her promotion, she was Chief Commercial Officer of Clinical Genomics. From December 2014 to September 2018, she served as President and Chief Operating Officer of Origin, Inc., a clinical-stage biotech company. From 2006 to April 2014, Ms. Hanna held positions of increasing responsibility at Johnson & Johnson, including as Vice President, Global Strategic Marketing -Acuvue Brand from October 2012 to April 2014, Vice President, Europe, Mideast and Africa at J&J Diagnostics from January 2010 to October 2012, and Vice President, Worldwide Marketing - Ortho Clinical Diagnostics from October 2006 to December 2009. She also served as a member of the Global Management Board for J&J Vision Care from October 2012 to April 2014. Ms. Hanna has a B.S. in Chemical Engineering from the University of llinois and an M.B.A. from Harvard Business School.